March 22, 2005Open Access

Survival After Recurrence of Ewing’s Sarcoma Family of Tumors

LBL. BarkerLeeds Teaching Hospitals NHS Trust TPThomas W. PendergrassUniversity of Washington JSJean E. SandersUniversity of Washington

Structured PICO

Does HDT as consolidation therapy improve overall survival in patients with relapsed Ewing's Sarcoma Family of Tumors?

Population

Patients with relapsed Ewing's Sarcoma Family of Tumors (ESFT)

Intervention

High-dose therapy (HDT) as consolidation therapy

Outcome

Overall survival (OS)hard clinical

High-dose therapy as consolidation may improve overall survival in patients with relapsed Ewing's Sarcoma Family of Tumors.

Abstract

HDT as consolidation therapy for relapsed ESFT seems to be associated with improved OS, even after adjusting for RFI and response to second-line treatment.

AIに質問

Bookmark

View Full Paper